[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Amneal Pharmaceuticals Inc (AMRX)

Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,716,436
  • Shares Outstanding, K 319,354
  • Annual Sales, $ 3,019 M
  • Annual Income, $ 72,060 K
  • EBIT $ 452 M
  • EBITDA $ 698 M
  • 60-Month Beta 1.27
  • Price/Sales 1.92
  • Price/Cash Flow 11.65
  • Price/Book 175.89

Options Overview Details

View History
  • Implied Volatility 44.22% (+0.11%)
  • Historical Volatility 38.31%
  • IV Percentile 3%
  • IV Rank 24.07%
  • IV High 175.93% on 03/30/26
  • IV Low 2.47% on 09/09/25
  • Expected Move (DTE 28) 1.40 (7.84%)
  • Put/Call Vol Ratio 1.07
  • Today's Volume 31
  • Volume Avg (30-Day) 180
  • Put/Call OI Ratio 0.67
  • Today's Open Interest 5,408
  • Open Int (30-Day) 3,819
  • Expected Range 16.50 to 19.30

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $0.26
  • Number of Estimates 1
  • High Estimate $0.26
  • Low Estimate $0.26
  • Prior Year $0.15
  • Growth Rate Est. (year over year) +73.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.77 +6.74%
on 08/12/26
19.26 -7.06%
on 07/29/26
+0.40 (+2.29%)
since 07/20/26
3-Month
11.94 +49.85%
on 05/21/26
19.26 -7.06%
on 07/29/26
+5.67 (+46.36%)
since 05/20/26
52-Week
9.20 +94.57%
on 08/27/25
19.26 -7.06%
on 07/29/26
+8.49 (+90.22%)
since 08/20/25

Most Recent Stories

More News
STOCK ALERT: Kaskela Law Announces Shareholder Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages Current AMRX Stockholders to Contact the Firm

Kaskela Law is investigating Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal”) on behalf of the company’s current shareholders. The investigation seeks to determine whether...

AMRX : 17.90 (-1.16%)
1 Russell 2000 Stock with Exciting Potential and 2 We Ignore

1 Russell 2000 Stock with Exciting Potential and 2 We Ignore

EVTC : 29.73 (-0.03%)
BAND : 48.15 (-7.93%)
AMRX : 17.90 (-1.16%)
3 Profitable Stocks That Fall Short

3 Profitable Stocks That Fall Short

MUR : 38.28 (+3.82%)
ENTG : 144.63 (+0.24%)
AMRX : 17.90 (-1.16%)
Amneal Completes Acquisition of Kashiv BioSciences, Creating a Global Biosimilar Leader

Establishes an integrated global platform spanning biosimilar R&D, manufacturing and commercialization  Adds a major long-term growth pillar and extends Amneal’s growth profile into the 2030s ...

AMRX : 17.90 (-1.16%)
1 Healthcare Stock Worth Your Attention and 2 We Ignore

1 Healthcare Stock Worth Your Attention and 2 We Ignore

ACHC : 26.97 (-1.43%)
HIMS : 31.86 (+2.48%)
AMRX : 17.90 (-1.16%)
5 Insightful Analyst Questions From Amneal’s Q2 Earnings Call

5 Insightful Analyst Questions From Amneal’s Q2 Earnings Call

AMRX : 17.90 (-1.16%)
AMRX Q2 Deep Dive: Diversified Product Mix and Biosimilars Strategy Shape Guidance

AMRX Q2 Deep Dive: Diversified Product Mix and Biosimilars Strategy Shape Guidance

AMRX : 17.90 (-1.16%)
Amneal (NASDAQ:AMRX) Beats Expectations in Strong Q2 CY2026, Stock Jumps 15.9%

Amneal (NASDAQ:AMRX) Beats Expectations in Strong Q2 CY2026, Stock Jumps 15.9%

AMRX : 17.90 (-1.16%)
Amneal: Q2 Earnings Snapshot

Amneal: Q2 Earnings Snapshot

AMRX : 17.90 (-1.16%)
Amneal Reports Second Quarter 2026 Financial Results

–  Q2 2026 Net Revenue of $796 million ; GAAP Net Income of $58 million ; Diluted Income per Share of $0.18 – – Adjusted EBITDA of $206 million ; Adjusted Diluted EPS of...

AMRX : 17.90 (-1.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories...

See More

Key Turning Points

3rd Resistance Point 18.33
2nd Resistance Point 18.18
1st Resistance Point 18.04
Last Price 17.90
1st Support Level 17.75
2nd Support Level 17.60
3rd Support Level 17.46

See More

52-Week High 19.26
Last Price 17.90
Fibonacci 61.8% 15.42
Fibonacci 50% 14.23
Fibonacci 38.2% 13.04
52-Week Low 9.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.